Search
Evoke Pharma Inc
EVOKAdd to Watchlist
11.000USD
0.0000.00%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
18.95MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
1
analysts
Hold
Current Rating
18.000
Target Price
+250.19%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
177
Total
6
Median
8
Average
Company name
Ratings
Analysts
Evoke Pharma Inc
EVOK
1
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
35
Vertex Pharmaceuticals Inc
VRTX
34
AbbVie Inc
ABBV
33
1
2
3
...
36
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Evoke Pharma Inc's expected revenue for the next quarter?
Evoke Pharma Inc's expected revenue is 4.86M.
What is Evoke Pharma Inc's price target?
Analysts forecast that Evoke Pharma Inc's price target is USD 18.00, with the highest forecast at USD 18.00 and the lowest forecast at USD 18.00.
How have Evoke Pharma IncEVOK's recent earnings per share performed?
The market expectation was USD -0.45, while Evoke Pharma IncEVOK's earnings per share (EPS) for the previous quarter was USD -0.62. EPS for the next quarter is expected at USD -0.30.
What is the analyst rating for Evoke Pharma Inc?
Based on the ratings of Evoke Pharma Inc's stock from 1 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.